Risk-Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers - A Systematic Review and Meta-Analysis
Favorite
Share
More Options
10

Open in WPS to view all 10 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
